Development of resistance to vincristine and doxorubicin in neuroblastoma alters malignant properties and induces additional karyotype changes: A preclinical model

International Journal of Cancer

Volumn 104, Issue 1, 2003, Pages 36-43

  Kotchetkov, Rouslan ^a   Cinatl, Jaroslav ^b   Blaheta, Roman ^a   Vogel, Jens Uwe ^a   Karaskova, Jana ^c   Squire, Jeremy ^c   Driever, Pablo Hernáiz ^d   Klingebiel, Thomas ^a   Cinatl Jr , Jindrich ^a,e  

^a GOETHE UNIVERSITY   (Germany)

^b KLINLAB   (Czech Republic)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e Center of Hygiene   (Germany)

Author keywords

Drug resistance; GD2; Karyotype; Mdt 1; NCAM; Neuroblastoma

Indexed keywords

CISPLATIN; CYTOTOXIC AGENT; DOXORUBICIN; GANGLIOSIDE GD2; GLYCOPROTEIN P; NERVE CELL ADHESION MOLECULE; RESERPINE; VERAPAMIL; VINCRISTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INVASION; CARCINOGENICITY; CELL ADHESION; CHROMOSOME ABERRATION; CLONOGENESIS; DRUG SENSITIVITY; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GROWTH RATE; HUMAN; HUMAN CELL; KARYOTYPE; LONG TERM CARE; MALIGNANT NEOPLASTIC DISEASE; MOUSE; MULTIDRUG RESISTANCE; NEUROBLASTOMA; NONHUMAN; ONCOGENE C MYB; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SPECTROSCOPY; TUMOR RESISTANCE;

EID: 0037430148     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10917     Document Type: Article

References (34)

1. Zoubek A, Holzinger B, Mann G, Peters C, Emminger W, Perneczky-Hintringer E, Gadner H, Mostbeck G, Horcher E, Dobrowsky W. High-dose cyclophosphamide, adriamycin, and vincristine (HD-CAV) in children with recurrent solid tumor. Pediatr Hematol Oncol 1994; 11:613-23.
2. Rubie H, Plantaz D, Coze C, Michon J, Frappaz D, Baranzelli MC, Chastagner P, Peyroulet MC, Hartmann O. Localised and unresectable neuroblastoma in infants: excellent outcome with primary chemotherapy. Neuroblastoma Study Group, Societe Francaise d'Oncologie Pediatrique. Med Pediatr Oncol 2001;36:247-50.
3. Keshelava N, Seeger RC, Groshen S, Reynolds CP. Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy. Cancer Res 1998;58:5396-405.
4. Bader P, Schilling F, Schlaud M, Girgert R, Handgretinger R, Klingebiel T, Treuner J, Liu C, Niethammer D, Beck JF. Expression analysis of multidrug resistance associated genes in neuroblastomas. Oncol Rep 1999;6:1143-6.
5. Bates SE, Shieh CY, Tsokos M. Expression of mdr-1 /P-glycoprotein in human neuroblastoma. Am J Pathol 1991;139:305-15.
6. Haber M, Kavallaris M. Multidrug resistance genes in neuroblastoma. In: Brodeur GM, Sawada T, Tsuchida Y, Voute PA, eds. Neuroblastoma. Amsterdam: Elsevier Science B.V, 2000. 207-15.
7. Norris MD, Bordow SB, Marshall GM, Haber PS, Cohn SL, Haber M. Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. N Engl J Med 1996; 334:231-8.
8. Kurowski C, Berthold F. Presence of classical multidrug resistance and P-glycoprotein expression in human neuroblastoma cells. Ann Oncol 1998;9:1009-14.
9. McMillan TJ, Hart IR. Enhanced experimental metastatic capacity of a murine melanoma following pre-treatment with anticancer drugs. Clin Exp Metastasis 1986;4:285-92.
10. Emanuel SL, Chamberlin HA, Cohen D. Antimitotic drugs cause increased tumorigenicity of multidrug resistant cells. Int J Oncol 1999;14:487-94.
11. Mattingly RR, Milstein ML, Mirkin BL. Down-regulation of growth factor-stimulated MAP kinase signaling in cytotoxic drug-resistant human neuroblastoma cells. Cell Signal 2001;13:499-505.
12. Ikushima S, Fujiwara F, Todo S, Imashuku S. Effects of polyunsaturated fatty acids on vincristine-resistance in human neuroblastoma cells. Anticancer Res 1991;11:1215-20.
13. Schrock E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA, Ning Y, Ledbetter DH, Bar-Am I, Soenksen D, Garini Y, Ried T. Multicolor spectral karyotyping of human chromosomes. Science 1996;273:494-7.
14. Cinatl J Jr, Cinatl J, Scholz M, Hernáiz Driever P, Henrich D, Kabickova H, Vogel J-U, Doerr H-W, Kornhuber B. Antitumor activity of sodium valproate in cultures of human neuroblastoma cells. Anti-Cancer Drugs 1996;7:766-773.
15. Schaeffer WI. Terminology associated with cell, tissue, and organ culture, molecular biology, and molecular genetics. Tissue Culture Association Terminology Committee. In Vitro Cell Dev Biol 1990; 26:97-101.
16. Cinatl J Jr, Cinatl J, Kotchetkov R, Matousek J, Woodcock BG, Köhl U, Vogel JU, Kornhuber B, Schwabe D. Bovine seminal ribonuclease exerts selectively cytotoxicity toward neuroblastoma cells both sensitive and resistant to chemotherapeutic drugs. Anticancer Res 2000; 20:853-60.
17. Davies R, Budworth J, Riley J, Snowden R, Gescher A, Gant TW. Regulation of P-glycoprotein I and 2 gene expression and protein activity in two MCF-7/Dox cell line subclones. Br J Cancer 1996;73:307-15.
18. Mitelman F. ISCN 1995. An international system for human cytogenetic nomenclature. Switzerland: S. Karger Publisher, Inc. (1995).
19. Miyamoto K, Wakusawa S, Nakamura S, Tajima K, Hidaka H. Multidrug resistance in Yoshida rat ascites hepatoma cell lines. Anticancer Res 1992;12:649-53.
20. Goodman LA, Liu BC, Thiele CJ, Schmidt ML, Cohn SL, Yamashiro JM, Pai DS, Ikegaki N, Wada RK. Modulation of N-myc expression alters the invasiveness of neuroblastoma. Clin Exp Metastasis 1997; 15:130-9.
21. Zaizen Y, Taniguchi S, Suita S. The role of cellular motility in the invasion of human neuroblastoma cells with or without N-myc amplification and expression. J Pediatr Surg 1998;33:1765-70.
22. Dole M, Nunez G, Merchant AK, Maybaum J, Rode CK, Bloch CA, Castle VP. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res 1994;54:3253-9.
23. Cinatl J Jr, Cinatl J, Vogel JU, Kotchetkov R, Hernáiz Driever P, Kabickova H, Kornhuber B, Schwabe D, Doerr HW. Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells. Cancer Res 1998;58:367-72.
24. Fulda S, Sieverts H, Friesen C, Herr I, Debatin KM. The CD95 (APO-/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res 1997;57:3823-9.
25. Hakomori S. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res 1996;56:5309-18.
26. Ladisch S, Kitada S, Hays EF. Gangliosides shed by tumor cells enhance tumor formation in mice. J Clin Invest 1987;9:1879-82.
27. Cinatl J Jr, Cinatl J, Kotchetkov R, Pouckova P, Vogel JU, Rabenau H, Michaelis M, Kornhuber B. Cytotoxicity of L-cycloserine against human neuroblastoma and medulloblastoma cells is associated with the suppression of ganglioside expression. Anticancer Res 1999;10: 5349-54.
28. Akeson R, Bernards R. N-myc down regulates neural cell adhesion molecule expression in rat neuroblastoma. Mol Cell Biol 1990;10: 2012-6.
29. Owens GC, Orr EA, DeMasters BK, Muschel RJ, Berens ME, Kruse CA. Overexpression of a transmembrane isoform of neural adhesion molecule alters the invasiveness of rat CNS-1 glioma. Cancer Res 1998;58:2020-8.
30. Vandesompele J, Speleman F, Van Roy N, Laureys G, Brinskchmidt C, Christiansen H, Lampert F, Lastowska M, Bown N, Pearson A, Nicholson JC, Ross F, et al. Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there? Med Pediatr Oncol 2001:36:5-10.
31. Van Roy N, Van Limbergen H, Vandesompele J, Van Gele M, Poppe B, Salwen H, Laureys G, Manoel N, De Paepe A, Speleman F. Combined M-FISH and CGH analysis allows comprehensive description of genetic alterations in neuroblastoma cell lines. Genes Chromosomes Cancer 2001;32:126-35.
32. Lastowska M, Van Roy N, Bown N, Speleman F, Roberts P, Lunec J, Strachan T, Pearson AD, Jackson MS. Molecular cytogenetic definition of 17q translocation breakpoints in neuroblastoma. Med Pediatr Oncol 2001;36:20-3.
33. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998;396:643-9.
34. Knutsen T, Mickley LA, Ried T, Green ED, du Manoir S, Schrock E, Macville M, Ning Y, Robey R, Polymeropoulos M, Torres R, Fojo T. Cytogenetic and molecular characterization of random chromosomal rearrangements activating the drug resistance gene, MDR1/P-glycoprotein, in drug-selected cell lines and patients with drug refractory ALL. Genes Chromosomes Cancer 1998;23:44-54.